Ikarian Capital »

Avalo Therapeutics Ord shares owned by Ikarian Capital

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.2M 970k 9.50
2024-06-30 $683k 55k 12.47
2024-03-31 $1.0M 47k 21.75

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Avalo Therapeutics Ord

Ikarian Capital
OrbiMed Advisors
RA Capital Management
BVF
Logos Global Management
Commodore Capital
Sio Capital Management
Affinity Asset Advisors
Vanguard Group
Geode Capital Management
Bank of America Corporation
BlackRock
BlackRock
Morgan Stanley
Efficient Wealth Management

View all funds holding Avalo Therapeutics Ord